Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
Cancer and Blood Specialists Clinic, Los Alamitos, California Florida Cancer Specialists, Lake Mary, Florida SCRI Oncology Partners, Nashville, Tennessee START Mountain Region, West Valley City, Utah